Showing results (111-120 of 530) with videos related to

Sort By:
Pageof 53
Cold Spring Harbor Symposia on Quantitative Biology|November 6, 2016
Functional Genomic Characterization of Cancer GenomesThomas P Howard, Francisca Vazquez, Aviad Tsherniak, et al.
Cancer Research|October 7, 2004
Signaling and transcriptional changes critical for transformation of human cells by simian virus 40 small tumor antigen or protein phosphatase 2A B56gamma knockdownCarlos S Moreno, Sumathi Ramachandran, Danita G Ashby, et al.
Genome Biology|December 21, 2021
Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effectsJoshua M Dempster, Isabella Boyle, Francisca Vazquez, et al.
Molecular and Cellular Biology|January 15, 2014
Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutationBoris G Wilson, Katherine C Helming, Xiaofeng Wang, et al.
American Journal of Clinical and Experimental Urology|November 9, 2023
Determining clinical perspectives and strategies for improving enrollment of minoritized communities in prostate cancer clinical trialsLauren Brady, Jenney R Lee, Evan Y Yu, et al.
BJU International|January 23, 2019
Chemotherapy regimen is associated with venous thromboembolism risk in patients with urothelial tract cancerJorge D Ramos, Sarah K Holt, George R Schade, et al.
The Prostate|July 11, 2018
Undetectable prostate-specific antigen after short-course androgen deprivation therapy for biochemically recurrent patients correlates with metastasis-free survival and prostate cancer-specific survivalDaniel M Lim, Roman Gulati, Serge Aleshin-Guendel, et al.
Investigational New Drugs|December 19, 2017
A randomized phase 2 study of a HSP27 targeting antisense, apatorsen with prednisone versus prednisone alone, in patients with metastatic castration resistant prostate cancerEvan Y Yu, Susan L Ellard, Sebastien J Hotte, et al.
Clinical Genitourinary Cancer|April 24, 2020
Phase 2 Trial of GTx-758, an Estrogen Receptor Alpha Agonist, in Men With Castration-Resistant Prostate CancerEvan Y Yu, Michael L Hancock, William Aronson, et al.
Blood|October 21, 2016
The EMT regulator ZEB2 is a novel dependency of human and murine acute myeloid leukemiaHubo Li, Brenton G Mar, Huadi Zhang, et al.
Pageof 53